Inozyme Pharma, Inc. (INZY) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts INZY Hot Sheet
Join SI Premium – FREE
Inozyme Pharma, Inc. (NASDAQ: INZY) reported Q1 EPS of ($0.38), $0.03 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Inozyme Pharma, Inc. (INZY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc eyes US banking license as next business step
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
